Domov>Klinične raziskave>Klinična preskušanja glede bolezni>Clinical implication of Retinitis Pigmentosa molecular diagnostic using high throughput sequencing (RP-SEQ-HD)

How to use the speech recognition tool?

NCT02860520

Clinical implication of Retinitis Pigmentosa molecular diagnostic using high throughput sequencing (RP-SEQ-HD)

Clinical implication of Retinitis Pigmentosa molecular diagnostic using high throughput sequencing (RP-SEQ-HD).

Type: Observational



Status of the trial: Unknown

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2015-09-01
  • Closing Date: 2018-09-30

Criteria

Inclusion: Retinopathy pigmentosa without molecular diagnosis

Exclusion: Retinopathy pigmentosa with molecular diagnosis

More information

Children: Yes

Adults: Yes

Funder Type: national institution

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: